The use of erythropoietin in dialysed patients leads to the gradual depletion of the body's iron reserves. It is important to assay iron blood levels in both patients receiving Epo therapy and those undergoing dialysis without this treatment. The most common method used is to assay ferritinemia, transferrinemia and the transferrin saturation levels. Using a retrospective study it was found that there is no significant difference in the request for iron supplementation in patients receiving Epo treatment compared to a control group not treated with Epo.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
patients receiving
8
receiving epo
8
[treatment erythropoietin
4
iron
4
erythropoietin iron
4
iron requirements
4
requirements dialyzed
4
dialyzed patients]
4
patients] erythropoietin
4
erythropoietin dialysed
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!